[HTML][HTML] Theranostics in oncology—thriving, now more than ever

RA Werner, T Higuchi, MG Pomper, SP Rowe - Diagnostics, 2021 - mdpi.com
Tracing its roots back to the 1940s, theranostics in nuclear oncology has proved successful
mainly due to the beneficial effects of image-guided therapeutic concepts for patients …

[HTML][HTML] Immunohistochemical expression of chemokine receptor in neuroendocrine neoplasms (CXCR4) of the gastrointestinal tract: a retrospective study of 71 cases

O Popa, SM Tăban, ALC Dema… - Romanian Journal of …, 2021 - ncbi.nlm.nih.gov
Aim: CXC motif chemokine receptor 4 (CXCR4) is expressed in many tumor entities,
including gastrointestinal neuroendocrine neoplasms (GI-NENs). However, the role of …

[HTML][HTML] Радиотераностика нейроэндокринных неоплазий: quo vadis

ПО Румянцев - Альманах клинической медицины, 2021 - cyberleninka.ru
Нейроэндокринные неоплазии объединены по принципу нейроэндокринного
происхождения и представлены гетерогенной группой опухолей различного …

Radiotheranostics of neuroendocrine neoplasms: quo vadis

PO Rumyantsev - Almanac of Clinical Medicine, 2021 - almclinmed.ru
Neuroendocrine neoplasms are grouped based on their neuroendocrine origin and
represented by a heterogeneous tumor cluster with various malignancy potentials and types …